BPH - Benign Prostatic Enlargement
Impact of preoperative therapy with 5-α-reductase inhibitors in the treatment of benign prostatic hyperplasia - Abstract
November 2, 2012
Real-world use of Permixon® in benign prostatic hyperplasia - determining appropriate monotherapy and combination treatment - Abstract
November 1, 2012
Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage - Abstract
October 30, 2012
Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - Abstract
October 29, 2012
Acute urinary retention increases the risk of complications after transurethral resection of the prostate: A population-based study - Abstract
October 29, 2012
LUTS and sleep disorders: Emerging risk factor - Abstract
October 26, 2012
Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery - Abstract
October 26, 2012
Histopathologic changes after bipolar resection of the prostate: Depth of penetration of bipolar thermal injury - Abstract
October 24, 2012
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells - Abstract
October 19, 2012
Self-report measurement of lower urinary tract symptoms: A commentary on the literature since 2011 - Abstract
October 18, 2012
Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia - Abstract
October 18, 2012
Dutasteride/tamsulosin: In benign prostatic hyperplasia - Abstract
October 17, 2012